Income statement
USD
Annual
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -374K | -319K | -271K | -229K | -311K |
| Operating Income | -3M | -6M | -5M | -7M | -9M |
| EBITDA | -10M | -10M | -14M | 27M | -37M |
| Net Income | -10M | -10M | -14M | 27M | -38M |
| EPS (Diluted) | — | — | — | — | — |
Financial Services
Live Price
Offline$0.49
+0.00% today
Window Change
+0.00%
Window
May 29, 2026 → Jun 18, 2026
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 15 bars · May 29, 2026 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Safeguard Scientifics, Inc. (SFES) is a Financial Services stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.49 and up 0.0% across the available one-year price window (May 29, 2026 → Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -1.6%, a dividend yield of 595.7%. What stands out right now is revenue 0.0%, EPS -1.6%, free cash flow +10.0% with operating margin 0.0% and ROIC -14.7%. The dividend matters to the case here, with a current yield around 595.7%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SFES price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SFES
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SFES Max Drawdown
-22.45%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SFES and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$37.6M
-239.3% YoY
Free Cash Flow
-$8.1M
+0.1% YoY
Revenue Growth
+0.0%
EPS Growth
-1.6%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -374K | -319K | -271K | -229K | -311K |
| Operating Income | -3M | -6M | -5M | -7M | -9M |
| EBITDA | -10M | -10M | -14M | 27M | -37M |
| Net Income | -10M | -10M | -14M | 27M | -38M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 7M | 9M | 13M | 25M | 16M |
| Total Assets | 11M | 23M | 38M | 54M | 69M |
| Total Liabilities | 1M | 3M | 3M | 3M | 6M |
| Shareholder Equity | 10M | 20M | 35M | 51M | 63M |
| Total Debt | 760K | 1M | 2M | 2M | 2M |
| Net Debt | -6M | -8M | -12M | -23M | -13M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
8M
+0.1% YoY
Capital Expenditures
0
Free Cash Flow
8M
+0.1% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-53.4%
Debt / Equity
0.05x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.